My research focuses on the biology and therapy of hemoglobinopathies, the molecular mechanisms underpinning hematopoiesis and the development of the leukemia stem cell, and the transcriptional mechanisms operative during the development of vertebrate organisms. Research projects include characterization of the key factors modulating developmental erythropoiesis, identification of gene regulatory networks in the neural crest and in neuroblastoma, and the development of allogenic stem cell transplant approaches to sickle cell disease. We collaborate with colleagues in developmental biology, informatics, and cancer biology to ensure that we bring a comprehensive perspective to the fundamental question we seek to solve.
            Clinical Hematology Branch, National Heart Lung and Blood Institute 
            National Institutes of Health, Bethesda, MD 
             - Hematology
            1993          
            Royal Free Hospital School of Medicine 
            London, United Kingdom
             - Wellcome Fellowship, Hematology
            1991          
            Kings College London
            United Kingdom
            MSc - Biochemistry
            1990          
            Mater Misericordiae Hospital
            Dublin, Ireland
             - Hematology Fellowship
            1987          
            Royal College of Physicians 
            United Kingdom
            Membership (MRCP) - Medicine
            1986          
            St Laurences Hospital
            Dublin, Ireland
             - Residency
            1985          
            University College Dublin
            Ireland
            MB BCh BAO - Medicine
            1982          
            Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant.
            Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant. Exp Hematol Oncol. 2019; 8:1.
            PMID: 30622841
          
            CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs.
            CisPi: a transcriptomic score for disclosing cis-acting disease-associated lincRNAs. Bioinformatics. 2018 09 01; 34(17):i664-i670.
            PMID: 30423099
          
            Immune Reconstitution Following Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma at the Time of Immunotherapy.
            Immune Reconstitution Following Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma at the Time of Immunotherapy. Biol Blood Marrow Transplant. 2018 03; 24(3):452-459.
            PMID: 29191664
          
            Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
            Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma. BMC Syst Biol. 2017 Oct 03; 11(Suppl 5):92.
            PMID: 28984200
          
            Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings.
            Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings. Pediatr Pulmonol. 2017 Nov; 52(11):1478-1485.
            PMID: 28486752
          
            A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).
            A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature). Sci Rep. 2017 03 03; 7(1):41.
            PMID: 28246384
          
            Noninvasive Measurement of mTORC1 Signaling with 89Zr-Transferrin.
            Noninvasive Measurement of mTORC1 Signaling with 89Zr-Transferrin. Clin Cancer Res. 2017 Jun 15; 23(12):3045-3052.
            PMID: 28007777
          
            Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience.
            Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience. Per Med. 2015 Jun; 12(3):221-229.
            PMID: 29771652
          
            Seq2pathway: an R/Bioconductor package for pathway analysis of next-generation sequencing data.
            Seq2pathway: an R/Bioconductor package for pathway analysis of next-generation sequencing data. Bioinformatics. 2015 Sep 15; 31(18):3043-5.
            PMID: 25979472
          
            Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia.
            Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia. BMC Bioinformatics. 2015 Mar 24; 16:97.
            PMID: 25887548
          
            Bucksbaum Senior Fellow
            Bucksbaum Institute, University of Chicago
            2017 - 2019          
            George M. Eisenberg Professor
            University of Chicago
            2017 - 2019          
            Pritzker Professor 
            University of Chicago
            2015 - 2017          
            Fogarty Fellowship
            National Institutes of Health
            1991 - 1993          
            Wellcome Fellowship
            Wellcome Trust
            1988 - 1991          
